Protagonist Therapeutics Inc
PTGX
$47.58+1.83 (+4.00%)
May 29, 2025, 4:00 PM
Financials
| 52Week High | 60.60 | 52Week Low | 27.00 |
| Beta | 2.23 | Current Ratio Annual | 12.48 |
| Current Ratio Quarterly | 17.26 | Market Cap | 2.93B |
| Net Profit Margin TTM | 27.04 | Operating Margin TTM | 13.10 |
| Price To Book | 4.25 | Price To Earnings TTM | 52.13 |
| Price To Free Cash Flow TTM | 7.45 | Price To Sales TTM | 14.10 |
| Quick Ratio Annual | 12.39 | Quick Ratio Quarterly | 17.13 |
| Return On Assets TTM | 8.31 | Return On Equity TTM | 9.22 |
| Return On Investment TTM | 9.22 | Revenue Growth3Y | 151.34 |
| Revenue Growth5Y | 352.10 | Revenue Growth Quarterly Yoy | -88.89 |
| Revenue Growth TTMYoy | -34.02 | Revenue Per Share TTM | 3.30 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 243 | 1 | 1 | 2 | 4 | 0 | 63.71M | $2.38B |
| Mar 31, 2025 | 273 | 68 | 32 | 90 | 87 | 23 | 66.84M | $3.10B |
| Change | 30(12%) | 67(6700%) | 31(3100%) | 88(4400%) | 83(2075%) | 23 | 3.14M(5%) | $720.07M(30%) |